Caplin Point Laboratories Limited's step-down subsidiary, M/s. Triwin Pharma S.A DE C.V, Mexico had acquired land measuring approximately 5.5 acres located at Municipality of Capulhuac, District of Tenango Del Valle, State of Mexico for the purpose of setting up a manufacturing facility.
In the initial phase, the unit will have the facility to manufacture Suppositories, Topicals and other products. Initial capacity expected to be 50 million units per annum.
The investment in land is USD 22,37,000 (INR 19.85 Crores) and the proposed investment in setting up the manufacturing facility is up to USD 15 million (INR 133 Crores)
The facility is targeted to be commissioned during FY 2027.
Shares of Caplin Point Laboratories Limited was last trading in BSE at Rs. 1924.25 as compared to the previous close of Rs. 1938.85. The total number of shares traded during the day was 6115 in over 893 trades.
The stock hit an intraday high of Rs. 1944.55 and intraday low of 1910.75. The net turnover during the day was Rs. 11771491.00.